Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Débora Claramunt"'
Publikováno v:
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
Pediatric chronic kidney disease (CKD) has peculiar features. In particular, growth impairment is a major clinical manifestation of CKD that debuts in pediatric age because it presents in a large proportion of infants and children with CKD and has a
Externí odkaz:
https://doaj.org/article/0a6cdfbf203a4a9e96b1bc2e29220dd7
Autor:
Cécile Acquaviva-Bourdain, Débora Claramunt-Taberner, Ségolène Gaillard, Irma Machuca-Gayet, Justine Bacchetta, Aurélia Bertholet-Thomas, Thomas Quinaux
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, MDPI, 2020, 21 (9), pp.3109. ⟨10.3390/ijms21093109⟩
International Journal of Molecular Sciences, 2020, 21 (9), pp.3109. ⟨10.3390/ijms21093109⟩
International Journal of Molecular Sciences, Vol 21, Iss 3109, p 3109 (2020)
International Journal of Molecular Sciences, MDPI, 2020, 21 (9), pp.3109. ⟨10.3390/ijms21093109⟩
International Journal of Molecular Sciences, 2020, 21 (9), pp.3109. ⟨10.3390/ijms21093109⟩
International Journal of Molecular Sciences, Vol 21, Iss 3109, p 3109 (2020)
International audience; Patients with chronic kidney disease (CKD) display significant mineral and bone disorders (CKD-MBD) that induce significant cardiovascular, growth and bone comorbidities. Nephropathic cystinosis is an inherited metabolic disor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c7d460248b7fba690fcf9144d0fbdf
https://hal.archives-ouvertes.fr/hal-03013184
https://hal.archives-ouvertes.fr/hal-03013184
Autor:
Flor A. Ordoñez, Fernando Santos, Olaya Hernández-Frías, Enrique García-López, Rocío Fuente, Helena Gil-Peña, Débora Claramunt, Vanessa Loredo, Julián Rodríguez-Suárez
Publikováno v:
American Journal of Physiology-Renal Physiology. 309:F57-F62
Growth retardation is a major manifestation of chronic kidney disease (CKD) in pediatric patients. The involvement of the various pathogenic factors is difficult to evaluate in clinical studies. Here, we present an experimental model of adenine-induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b958a78bbbe63b029314c6a75c6e081d
https://doi.org/10.1152/ajprenal.00051.2015
https://doi.org/10.1152/ajprenal.00051.2015
Publikováno v:
Scopus
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Nefrología (English Edition), Vol 35, Iss 6, Pp 517-522 (2015)
Nefrología (Madrid) v.35 n.6 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Nefrología, Vol 35, Iss 6, Pp 517-522 (2015)
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Nefrología (English Edition), Vol 35, Iss 6, Pp 517-522 (2015)
Nefrología (Madrid) v.35 n.6 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Pediatric chronic kidney disease (CKD) has peculiar features. In particular, growth impairment is a major clinical manifestation of CKD that debuts in pediatric age because it presents in a large proportion of infants and children with CKD and has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f03adf61c635658767762765cde92f4
http://hdl.handle.net/10651/36871
http://hdl.handle.net/10651/36871
Autor:
Rocío Fuente, Flor A. Ordoñez, Fernando Santos, Enrique García-López, Julián Rodríguez-Suárez, Olaya Hernández Frías, Helena Gil-Peña, Débora Claramunt
Publikováno v:
Pediatric Research. 82:888-888
BackgroundIn a model of growth retardation secondary to chronic kidney disease (CKD) induced by adenine, this study explores the effects of growth hormone (GH) therapy on growth plate and mineral metabolism.MethodsWeaning female rats receiving a 0.5%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0654ac13d6054f1b2b9aa0706a5e0a
https://doi.org/10.1038/pr.2017.205
https://doi.org/10.1038/pr.2017.205